Target intelligence / Profile preview

Apolipoprotein B mRNA editing enzyme, catalytic polypeptide-like 3 family pseudogene

Molecular classification
Pseudogene, Processed pseudogene (retrotransposed pseudogene)
01

Overview

ENSG00000225720 encodes a pseudogene belonging to the apolipoprotein B mRNA editing enzyme, catalytic polypeptide-like 3 (APOBEC3) family[5]. Pseudogenes are typically non-functional sequences resembling protein-coding genes but lacking the ability to encode functional proteins, usually due to mutations, truncations, or absence of regulatory elements[2][4][6]. Processed (retrotransposed) pseudogenes like this one are created when mRNA from a functional gene is reverse-transcribed and inserted back into the genome[2][4][6]. While most pseudogenes do not produce active RNA or protein products, a minority can play regulatory roles in gene expression (via microRNA decoys, for example), but no such function has been described for ENSG00000225720[6]. This locus is not considered a therapeutic target, does not encode a protein, and has no known role in signaling, transport, or disease as a direct drug target[5].

Other names
Apolipoprotein B mRNA editing enzyme, catalytic polypeptide-like 3 pseudogeneAPOBEC3 family pseudogeneGC22P039487 (and other historical GeneCards IDs)
02

Biological functions

None (pseudogene; lacks protein-coding function)
03

Disease associations

Other (occasional regulatory effects discussed for some pseudogenes in general, but not for this specific entry)

Beyond the preview

Go deeper on Apolipoprotein B mRNA editing enzyme, catalytic polypeptide-like 3 family pseudogene.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Apolipoprotein B mRNA editing enzyme, catalytic polypeptide-like 3 family pseudogene.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call